How Would You Manage This Patient With Clostridioides difficile Infection? : Grand Rounds Discussion From Beth Israel

Zahir Kanjee1, Jessica R Allegretti2, Carolyn D Alonso3

  • 1Division of General Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (Z.K., R.B.B.).

PubMed

Insights

Updated guidelines for Clostridioides difficile infection management offer differing advice on antibiotic treatments for nonsevere disease and fecal microbiota transplantation for severe cases. Experts discuss these key differences in clinical practice.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Clinical Practice Guidelines

Background:

  • The Infectious Diseases Society of America/Society for Healthcare Epidemiology of America and the American College of Gastroenterology have issued new guidelines for managing Clostridioides difficile infection.
  • These guidelines present generally aligned recommendations but include notable divergences in clinical advice.

Observation:

  • Two experts, an infectious diseases specialist and a gastroenterologist, engage in a discussion regarding the updated guidelines.
  • The discussion centers on antibiotic choices for nonsevere C. difficile infection, the utility of fecal microbiota transplantation in fulminant disease, and the application of bezlotoxumab for preventing recurrence.

Findings:

  • The experts analyze specific treatment strategies, including antibiotic options for nonsevere disease and the role of fecal microbiota transplantation for fulminant cases.
  • The use of bezlotoxumab to prevent recurrent C. difficile infection is examined within a clinical case scenario.

Implications:

  • Clinicians must navigate nuanced differences between major society guidelines for optimal patient care.
  • Understanding these distinctions is crucial for effective management of Clostridioides difficile infection, particularly in severe and recurrent cases.

Related Concept Videos

Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...